FTC sues key pharmacy benefit managers about insulin costs The agency brought motion versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist price of daily life-conserving insulin prescription drugs. This plan aligns with All those endeavours, the ONC explained. The industry https://busch-light-peach-nutriti05049.kylieblog.com/31166850/healthcare-news-secrets